Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cutting Edge: Effector Memory CD8+ T Cells in the Lung Airways Retain the Potential to Mediate Recall Responses

Kenneth H. Ely, Alan D. Roberts and David L. Woodland
J Immunol October 1, 2003, 171 (7) 3338-3342; DOI: https://doi.org/10.4049/jimmunol.171.7.3338
Kenneth H. Ely
Trudeau Institute, Saranac Lake, NY 12983
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan D. Roberts
Trudeau Institute, Saranac Lake, NY 12983
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David L. Woodland
Trudeau Institute, Saranac Lake, NY 12983
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Previous studies have shown that long-lived memory CD8+ T cells persist in the lung airways following the resolution of a murine Sendai virus infection. These cells are CD11alow, noncytolytic, and do not proliferate in the lung airways raising the possibility that they are “end stage” or terminally differentiated memory cells. In this current report, we investigated the functional characteristics of these cells by analyzing their capacity to respond to secondary viral infection outside of the lung environment. We show that, after transfer into the bloodstream, CD11alow memory T cells from the lung airways can return to the secondary lymphoid tissue and respond to a secondary viral challenge. Furthermore, these cells re-express CD11a, which may contribute to their migratory and proliferative capacity. These data demonstrate that lung airway memory CD8+ T cells are not terminally differentiated cells and retain the capacity to mediate recall responses to infection.

T cells (CD8+) play a central role in the control of acute respiratory virus infections through the secretion of antiviral cytokines and lysis of infected lung epithelial cells (1, 2, 3). Following resolution of the infection, a population of long-lived effector memory CD8+ T cells is established in the lung airways (4, 5). These resident lung airway memory CD8+ T cells display a highly activated phenotype characterized by the expression of acute activation markers, such as CD69 and CD25. However, these cells are not in cycle and persist in the airways with a half-life of ∼40 days (5). Interestingly, the declining number of resident lung airway memory cells correlates with the declining efficacy of cellular memory against secondary infection, suggesting that these cells play an important role in the control of secondary infections (6). In support of this, lung airway memory T cells have been shown to mediate substantial antiviral activity in a Sendai virus model (7). The underlying mechanism of viral control is not known, but it is likely that early cytokine production may play a key role in reducing viral replication.

Despite the role that lung airway memory cells may play in controlling viral infections, they do not proliferate in the lung airways following secondary Sendai virus infection (8, 9). In addition, the majority of CD8+ memory cells in the lung airways express CD11a at low levels which distinguishes them from memory T cells at other sites (8, 10). These observations raise the question of whether CD11alow memory cells in the lung airways are simply end-stage cells or whether they are maintained in a nonproliferative state by the lung environment. To address this issue, we used an adoptive transfer system that allowed direct comparison between the proliferative ability of intratracheally (i.t.)3 and i.v. transferred memory T cells from the lung airways during secondary Sendai virus infection. We demonstrate that memory cells from the lung airways include cells that retain the ability to proliferate and migrate in response to homologous infection when transferred systemically. These data indicate that the lung environment normally limits the expansion of these cells in response to cognate Ag despite the fact that they retain the potential to mediate recall responses to infection.

Materials and Methods

Viruses, mice, and infection

Sendai virus (Enders strain) was grown, stored, and titered as previously described (1). Female C57BL/6, B6.Pl-Thy1a/Cy (Thy1.1), and B6.SJL-Ptprca Pep3/BoyJ (CD45.1) mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Animals were housed under specific pathogen-free conditions. Mice (6–8 wk) were anesthetized by i.p. injection of 2,2,2-tribromoethanol and intranasally infected with 250 50% egg infectious doses (EID50) of Sendai virus.

Bronchoalveolar lavage (BAL)

Mice were anesthetized and then bled by cutting the descending aorta. Lung airway cells were collected by five consecutive 1-ml lavages with HBSS. Cells were adhered on plastic for 1 h and nonadherent cells were collected for FACS analysis. Collected cells were either stained with anti-CD11a PE (BD PharMingen, San Diego, CA) for sorting or CFSE-labeled as described below.

CFSE staining and adoptive transfer of BAL cells

In one set of experiments, Thy1.1+ and CD45.1+ Sendai memory mice were euthanized and lung airway cells were collected as described above. BAL cells were stained with 0.5 μM CFSE for 10 min at room temperature and were washed extensively. Labeled cells were resuspended in 100 μl/HBSS and transferred into naive C57BL/6 recipient mice by i.t. instillation using a blunted and bent 20-gauge needle at a donor to host ratio of 5:1. Recipient mice were then challenged with an intranasal infection with 250 EID50 Sendai virus.

Tissue harvest, preparation, and flow cytometry

BAL were harvested from recipient mice 11 or 12 days postinfection. Harvested cells were stained with allophycocyanin-conjugated tetramer specific for the immunodominant Sendai NP epitope (NP324–332/Kb) for 1 h, followed by staining with PerCP-conjugated anti-CD8, and either PE-conjugated anti-Thy1.1 or anti-CD45.1 Abs for 20 min and fixed overnight. Stained samples were analyzed as described below. In other experiments, BAL cells were collected, plastic-adhered, and stained with anti-CD11a PE for 20 min. Stained cells were sorted into CD11ahigh and CD11alow populations on a FACSVantage cell sorter (BD Immunocytometry Systems, San Jose, CA) with diva enhancement software, CFSE-labeled, and transferred into naive recipients as above or sorted cells were transferred without CFSE and stained as above with the exception of the addition of anti-CD11a FITC in place of CFSE.

Flow cytometry

MHC class I-peptide tetramers were generated by the Molecular Biology Core Facility (Trudeau Institute, Saranac Lake, NY) as described previously (11). Cells were stained with NP324–332/Kb allophycocyanin-specific tetramer for 1 h at room temperature as previously described (5). Tetramer-labeled cells were then stained with anti-CD8 PerCP and FITC-conjugated mAbs specific for CD11a, and PE-conjugated mAbs specific for Thy1.1 (BD PharMingen, San Diego, CA) or CD45.1 (eBioscience, San Diego, CA) on ice for 20 min and fixed overnight with 1% paraformaldehyde in PBS. Samples were run on a BD Biosciences FACSCalibur flow cytometer (San Jose, CA) and data were analyzed using FlowJo software (Treestar, San Carlos, CA). The percentage of tetramer-positive cells among CD8+ T cells was calculated by dividing the number of tetramer-positive CD8+ events by the total number of events in the CD8+ gate. The absolute number of tetramer-positive cells was calculated using the percentage of tetramer-positive cells among the total live cell gate and the number of cells isolated per mouse in each tissue as indicated by trypan blue staining.

Results and Discussion

Lung airway resident memory CD8+ T cells retain the ability to proliferate in vivo

To analyze the functional capacity of lung airway memory cells, the BAL was collected from CD45.1+ congenic donor mice that had recovered from a Sendai virus infection. The cells were plastic-adhered and nonadherent cells were CFSE-labeled and i.v. transferred into CD45.2+ naive recipient mice. One day later, recipient mice were intranasally infected with a sublethal dose of Sendai virus. Eleven days postinfection (12 days posttransfer), the recipient mice were killed and cells from lung airways and lung parenchyma, draining lymph node, and spleen were isolated and examined for the presence of donor (CD45.1+) NP324–332/Kb-specific memory T cells. As shown in Fig. 1⇓, donor memory T cells were found in the lung airways, lung parenchyma, draining lymph node, and the spleen 12 days posttransfer. All of the recovered cells expressed low levels of CFSE indicating that they had proliferated extensively following Sendai virus infection of the recipient. Consistent with this, the number of cells recovered had increased from an input of ∼4,600 NP324–332/Kb-specific T cells to >30,000 cells in the lungs, mediastinal lymph node (MLN) and spleen combined by 12 days posttransfer. This level of expression was similar to that observed using splenocytes from mice that had recovered from Sendai virus infection as donor cells (an average 20-fold expansion of Ag-specific donor cells with no expansion observed during an irrelevant influenza infection, data not shown). In addition, we also found that i.v.-transferred lung airway memory cells could be detected in the lung airways 36 days posttransfer (data not shown) indicating that these cells develop into lung airway resident memory T cells following resolution of the infection. These results demonstrate that lung airway resident memory CD8+ T cells retain the ability to proliferate and migrate in response to homologous infection following systemic transfer.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

CD8 memory T cells from the lung airways proliferate after i.v. transfer. BAL was collected from CD45.1+ 30–35 day Sendai memory mice, CFSE-labeled, and transferred i.v. into naive C57BL/6-recipient mice which were then intranasally infected with 250 EID50 Sendai virus on the following day. The profile of CFSE-labeled donor cells is shown in the upper right panel. Eleven days postinfection (12 days posttransfer), the recipient mice were euthanized and BAL, lungs, MLN, and spleen were harvested and cells were analyzed by FACS for the expression of CD45.1, CD8, NP324–332/Kb tetramer, and CFSE intensity (lower panels). Lower left panels are lymphocyte gates and lower right panels are the cells represented by the circled gate in the lower left panels. The numbers in the right panels represent the total number of donor cells transferred or recovered. Data are representative of two separate experiments.

In separate experiments, we also compared the ability of lung airway memory T cells to proliferate following simultaneous i.t. and i.v. transfer. Thus, BAL cells from either Thy1.1+ or CD45.1+ donor mice were transferred either i.t. (Thy1.1+) or i.v. (CD45.1+) into the same CD45.2+, Thy1.2+ recipient mice and then intranasally infected with Sendai virus. Eleven days postinfection, the numbers and distribution of i.t.-transferred (Thy1.1) and i.v.-transferred (CD45.1) donor cells were determined. As shown in Fig. 2⇓, despite a strong proliferative and migratory response of the i.v. transferred cells (∼20,000 NP324–332/Kb-specific cells detected in the lung airways 11 days post-Sendai virus infection), we were unable to detect i.t.-transferred cells. These data are consistent with previous studies showing that i.t.-transferred memory cells do not expand in the lung following viral challenge and are deleted during the acute inflammatory response (7, 8, 9). Thus, these results suggest the lung environment controls the proliferative capacity and survival of these memory cells.

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

CD8 memory T cells present in the lung airways disappear during secondary infection. BAL was collected from both Thy1.1+ and CD45.1+ Sendai memory mice, CFSE-labeled, and transferred either i.t. or i.v., respectively, into the same naive C57BL/6 recipient mice, which were then intranasally infected with 250 EID50 Sendai virus on the following day. BAL was harvested 12 days postinfection and nonadherent cells were stained for either Thy1.1 to identify i.t.-transferred cells or CD45.1 to identify i.v.-transferred cells. Gated populations of NP-specific CD8+ T cells and CFSE intensity are shown. Upper panels, Intravenously transferred CD45.1+ cells recovered within the lymphocyte gate (left) and the NP324–332/Kb and CFSE profiles of cells within the CD45.1, CD8 gate (right). Lower left panel, There were no i.t.-transferred CD8+, Thy1.1+ cells recovered. Data shown are one of two separate experiments.

CD11alow BAL cells migrate and proliferate in response to homologous infection after i.v. transfer

The previous data demonstrate that lung airway memory cells are able to proliferate when removed from the lung environment. However, it is possible that the data in Fig. 1⇑ represent the outgrowth of a small percentage of contaminating cells from the lung parenchyma or recent immigrants that express high levels of CD11a (5). Indeed, we have recently shown that recent arrivals to the lung airway express higher levels of CD11a and then progressively lose this high expression over time (8). To address this issue, we isolated lung airway memory cells from CD45.1+ donor mice that expressed low levels of CD11a by FACS. Sorted CD11alow cells were then i.v. transferred into C57BL/6 (CD45.2+) recipient mice and intranasally infected with Sendai virus as described above. Donor cells were recovered from the airways and parenchymal tissue of the lung, as well as, draining lymph node and spleen on day 11 post-Sendai virus infection. As demonstrated in Fig. 3⇓, columns A and B, the transferred CD11alow Sendai memory cells proliferated in response to homologous infection as shown by the decrease in CFSE intensity. This proliferation resulted in a 5-fold increase in the total number of NP324-332/Kb-specific donor T cells recovered from recipient mice (Table I⇓). These data confirm that CD11alow memory cells in the lung airways retain the ability to mediate recall responses by proliferating and migrating to the site of infection following Sendai virus challenge. Furthermore, the data indicate that i.v.-transferred CD11alow lung airway memory T cells isolated 11 days after Sendai virus infection up-regulated CD11a in all tissues examined (Fig. 4⇓). CD11a is an adhesion and activation marker that is involved in the extravasation of cells out of the circulation. The loss or blockade of this molecule can impair T cell trafficking. For example, pretreatment of transferred effector cells with anti-LFA-1 Ab resulted in decreased endothelial cells adhesion and retention of transferred cells in the lung compared with control treated animals (12). Thus, the re-expression of CD11a on i.v.-transferred BAL cells may account for their ability to migrate throughout the recipient host.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

CD11alow virus-specific lung airway memory cells proliferate and migrate in an IL-15-independent manner during secondary virus infection after transfer. BAL was collected from CD45.1 memory mice, FACS sorted for CD11alow and CD11ahigh populations (upper left, postsort composite). The CD11alow population was CFSE-labeled (upper hand panel) and transferred i.v. into naive C57BL/6 or IL-15−/− (CD45.2) recipient mice. Recipient mice were intranasally infected with 250 EID50 Sendai virus the following day. Eleven days postinfection (12 days post transfer), the recipient mice were euthanized and BAL, lungs, MLN, and spleen were harvested and cells were analyzed by FACS for the expression of CD45.1, CD8, NP324–332/Kb tetramer, and CFSE intensity. Columns A and B, The distribution of NP324–332/Kb tetramer and CFSE-labeled cells from the CD45.1+, CD8+ cells within the lymphocyte gate collected from C57BL/6 recipients. Columns C and D, The distribution of NP324–332/Kb tetramer and CFSE-labeled cells from the CD45.1+, CD8+ cells within the lymphocyte gate collected from IL-15−/− recipients. Data shown are representative of two separate experiments.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Intravenously transferred CD11alow lung airway memory cells re-express higher levels of CD11a during Sendai virus infection of naive hosts. BAL was collected from CD45.1 memory mice, FACS sorted for CD11alow and CD11ahigh populations (upper left composite postsort). The Cd11alow population was and transferred i.v. into naive CD45.2 recipient mice. Recipient mice were intranasally infected with 250 EID50 Sendai virus the following day. Eleven days postinfection, the recipient mice were euthanized and BAL, lungs, MLN, and spleen were harvested and cells were analyzed by FACS for the expression of CD45.1, CD8, and CD11a. Panels show the distribution of CD11a on cells within the CD45.1, CD8 gate.

View this table:
  • View inline
  • View popup
Table I.

Intravenously transferred CD11alow lung airway memory T cells proliferate and migrate to the lungs in C57BL/6-recipient mice following intranasal Sendai virus infectiona

IL-15, along with IL-7, has been identified as a factor necessary for homeostatic maintenance of memory CD8+ T cells (13, 14, 15) and also induces chemokines that attract activated or memory CD8+ T cells to the site of inflammation (16). However, the role of IL-15 in the initial expansion of CD8+ cells and the generation of memory is less clear. Some reports cite a requirement for IL-15 (17), while in other systems it is reported that IL-15 is dispensable for the generation of CD8+ memory cells (15, 18). Thus, we investigated whether lung resident CD11alow memory cells required host IL-15 to respond to proliferate and extravasate back into the lung airways following i.v. transfer. As shown in Fig. 3⇑, columns C and D, lung airway CD11alow memory cells proliferated and migrated back to the lung airways in IL-15−/−-recipient mice following Sendai virus infection demonstrating that host IL-15 is not required for this response.

Taken together, the data show that lung airway resident memory T cells retain the potential to proliferate, re-express CD11a, and migrate to the site of infection in the lung airways following i.v. transfer indicating that they are not terminally differentiated cells. However, these same cells failed to proliferate and persist when placed directly into the lung airways suggesting that the lung environment is not permissive for the proliferation of these cells. In this regard, it has been reported that local factors, such as lung surfactants may inhibit the proliferation of T cells in the lung (19, 20, 21, 22). It is possible that inhibition of T cell proliferation in nonlymphoid tissues is an important mechanism to avoid inappropriate or dysregulated T cell response. Thus, it may be the case that T cell proliferation is always restricted to lymphoid tissues to ensure appropriate regulation of the response. Furthermore, the failure of T cells proliferate in the lung airways suggests that the size of the memory deposited in the lung airways is a function of the magnitude of recruitment to the airways during resolution of the infection. This hypothesis, along with the observation that lung airway memory cells are able to mediate recall responses, has implications for the development of vaccines designed to promote cellular immunity in the lung.

Acknowledgments

We thank Scottie Adams, Tim Miller, and Mark LaMere of the Trudeau Institute Molecular Biology Core Facility for the generation of tetrameric reagents and Drs. Linda Cauley, Marcia Blackman, and Markus Mohrs for critically reading the manuscript.

Footnotes

  • ↵1 This work was supported by National Institutes of Health Grants HL63925, HL69502, AI49823 (to D.L.W.) and the Trudeau Institute.

  • ↵2 Address correspondence and reprint requests to Dr. David L. Woodland, Trudeau Institute, 100 Algonquin Avenue, P.O. Box 59, Saranac Lake, NY 12983. E-mail address: dwoodland{at}trudeauinstitute.org

  • ↵3 Abbreviations used in this paper: i.t., intratracheal; BAL, bronchoalveolar lavage; EID50, 50% egg infectious dose; MLN, mediastinal lymph node.

  • Received July 2, 2003.
  • Accepted August 11, 2003.
  • Copyright © 2003 by The American Association of Immunologists

References

  1. ↵
    Hou, S., L. Hyland, K. W. Ryan, A. Portner, P. C. Doherty. 1994. Virus-specific CD8+ T-cell memory determined by clonal burst size. Nature 369:652.
    OpenUrlCrossRefPubMed
  2. ↵
    Flynn, K. J., G. T. Belz, J. D. Altman, R. Ahmed, D. L. Woodland, P. C. Doherty. 1998. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8:683.
    OpenUrlCrossRefPubMed
  3. ↵
    Lukacher, A. E., V. L. Braciale, T. J. Braciale. 1984. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J. Exp. Med. 160:814.
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Ostler, T., T. Hussell, C. D. Surh, P. Openshaw, S. Ehl. 2001. Long-term persistence and reactivation of T cell memory in the lung of mice infected with respiratory syncytial virus. Eur. J. Immunol. 31:2574.
    OpenUrlCrossRefPubMed
  5. ↵
    Hogan, R. J., E. J. Usherwood, W. Zhong, A. A. Roberts, R. W. Dutton, A. G. Harmsen, D. L. Woodland. 2001. Activated antigen-specific CD8+ T cells persist in the lungs following recovery from respiratory virus infections. J. Immunol. 166:1813.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Liang, S., K. Mozdzanowska, G. Palladino, W. Gerhard. 1994. Heterosubtypic immunity to influenza type A virus in mice: effector mechanisms and their longevity. J. Immunol. 152:1653.
    OpenUrlAbstract
  7. ↵
    Hogan, R. J., W. Zhong, E. J. Usherwood, T. Cookenham, A. D. Roberts, D. L. Woodland. 2001. Protection from respiratory virus infections can be mediated by antigen-specific CD4+ T cells that persist in the lungs. J. Exp. Med. 193:981.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Ely, K. H., L. S. Cauley, A. D. Roberts, J. W. Brennan, T. Cookenham, D. L. Woodland. 2003. Nonspecific recruitment of memory CD8+ T cells to the lung airways during respiratory virus infections. J. Immunol. 170:1423.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Harris, N. L., V. Watt, F. Ronchese, G. Le Gros. 2002. Differential T cell function and fate in lymph node and nonlymphoid tissues. J. Exp. Med. 195:317.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Lefrancois, L.. 2002. Dual personality of memory T cells. Trends Immunol. 23:226.
    OpenUrlCrossRefPubMed
  11. ↵
    Altman, J. D., P. H. Moss, P. R. Goulder, D. H. Barouch, M. G. McHeyzer-Williams, J. I. Bell, A. J. McMichael, M. M. Davis. 1996. Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Thatte, J., V. Dabak, M. B. Williams, T. J. Braciale, K. Ley. 2003. LFA-1 is required for retention of effector CD8 T cells in mouse lungs. Blood 101:4916.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Tan, J. T., B. Ernst, W. C. Kieper, E. LeRoy, J. Sprent, C. D. Surh. 2002. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J. Exp. Med. 195:1523.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    Judge, A. D., X. Zhang, H. Fujii, C. D. Surh, J. Sprent. 2002. Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8+ T cells. J. Exp. Med. 196:935.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Becker, T. C., E. J. Wherry, D. Boone, K. Murali-Krishna, R. Antia, A. Ma, R. Ahmed. 2002. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 195:1541.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Perera, L. P., C. K. Goldman, T. A. Waldmann. 1999. IL-15 induces the expression of chemokines and their receptors in T lymphocytes. J. Immunol. 162:2606.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    Schluns, K. S., K. Williams, A. Ma, X. X. Zheng, L. Lefrancois. 2002. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168:4827.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Wherry, E. J., T. C. Becker, D. Boone, M. K. Kaja, A. Ma, R. Ahmed. 2002. Homeostatic proliferation but not the generation of virus specific memory CD8 T cells is impaired in the absence of IL-15 or IL-15Rα. Adv. Exp. Med. Biol. 512:165.
    OpenUrlCrossRefPubMed
  19. ↵
    Borron, P. J., E. C. Crouch, J. F. Lewis, J. R. Wright, F. Possmayer, L. J. Fraher. 1998. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and IL-2 production. J. Immunol. 161:4599.
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Kremlev, S. G., T. M. Umstead, D. S. Phelps. 1994. Effects of surfactant protein A and surfactant lipids on lymphocyte proliferation in vitro. Am. J. Physiol. 267:L357.
    OpenUrlPubMed
  21. ↵
    Wilsher, M. L., D. A. Hughes, P. L. Haslam. 1988. Immunoregulatory properties of pulmonary surfactant: effect of lung lining fluid on proliferation of human blood lymphocytes. Thorax 43:354.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Yao, L. J., L. J. Fraher, R. A. Veldhuizen, S. Samuelson, P. Borron, J. Malloy, L. McCaig, J. F. Lewis. 2001. Effects of alveolar surfactant aggregates on T-lymphocyte proliferation. Biochim. Biophys. Acta 1535:266.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

The Journal of Immunology: 171 (7)
The Journal of Immunology
Vol. 171, Issue 7
1 Oct 2003
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cutting Edge: Effector Memory CD8+ T Cells in the Lung Airways Retain the Potential to Mediate Recall Responses
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cutting Edge: Effector Memory CD8+ T Cells in the Lung Airways Retain the Potential to Mediate Recall Responses
Kenneth H. Ely, Alan D. Roberts, David L. Woodland
The Journal of Immunology October 1, 2003, 171 (7) 3338-3342; DOI: 10.4049/jimmunol.171.7.3338

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cutting Edge: Effector Memory CD8+ T Cells in the Lung Airways Retain the Potential to Mediate Recall Responses
Kenneth H. Ely, Alan D. Roberts, David L. Woodland
The Journal of Immunology October 1, 2003, 171 (7) 3338-3342; DOI: 10.4049/jimmunol.171.7.3338
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results and Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cutting Edge: T Cell Responses to B.1.1.529 (Omicron) SARS-CoV-2 Variant Induced by COVID-19 Infection and/or mRNA Vaccination Are Largely Preserved
  • Cutting Edge: SARS-CoV-2 Infection Induces Robust Germinal Center Activity in the Human Tonsil
  • Cutting Edge: Enhanced Antitumor Immunity in ST8Sia6 Knockout Mice
Show more CUTTING EDGE

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606